Trevor Blake: $300M Exits While Working Less Than 5 Hours A Day #MindsetSeries
Capitalism.com with Ryan Daniel Moran
00:00
Is the Buyer of a Pharmaceutical or Biotech Company Buying the Technology?
The company probably doesn't have any substantial revenue. It is not the traditional model of developing something and getting it to $100 million in revenue and then selling it. You're just developing an asset that somebody else is going to put into a revenue stream. The question of valuation always comes up. How can you value an idea that highly? And so they're offering this much now, which is a big chunk of money,. But I'm not leaving at that point. So I'm willing to take a little bit of risk. That's why I say it's between $600 million and a billion.
Transcript
Play full episode
